Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Januvia in Cystic Fibrosis-related Diabetes
NCT01257464Phase 2Terminated
- Sponsor
- University of British Columbia
- Start
- Sep 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in cystic fibrosis-related diabetes (CFRD), sponsored by University of British Columbia. Started Sep 2010; status: terminated.
02
Drugs
sitagliptin
03
Conditions
cystic fibrosis-related diabetes (CFRD)
Beyond the preview
Go deeper on NCT01257464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257464.